Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Revenue: 2021-2025

Historic Revenue for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to $97.8 million.

  • Krystal Biotech's Revenue rose 16.65% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $373.2 million, marking a year-over-year increase of 54.46%. This contributed to the annual value of $290.5 million for FY2024, which is 473.01% up from last year.
  • Latest data reveals that Krystal Biotech reported Revenue of $97.8 million as of Q3 2025, which was up 1.83% from $96.0 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Revenue registered a high of $97.8 million during Q3 2025, and its lowest value of -$1.5 million during Q1 2021.
  • For the 3-year period, Krystal Biotech's Revenue averaged around $69.3 million, with its median value being $83.8 million (2024).
  • Data for Krystal Biotech's Revenue shows a peak YoY soared of 879.91% (in 2024) over the last 5 years.
  • Over the past 4 years, Krystal Biotech's Revenue (Quarterly) stood at -$1.5 million in 2021, then reached $42.1 million in 2023, then surged by 116.20% to $91.1 million in 2024, then climbed by 16.65% to $97.8 million in 2025.
  • Its Revenue was $97.8 million in Q3 2025, compared to $96.0 million in Q2 2025 and $88.2 million in Q1 2025.